Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 63 (5) , 1801-1808
- https://doi.org/10.1046/j.1523-1755.2003.00915.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- PTH Metabolites in Renal Failure: Bioactivity and Clinical ImplicationsSeminars in Dialysis, 2002
- Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid FunctionJournal of Bone and Mineral Research, 2001
- A novel mechanism for skeletal resistance in uremiaKidney International, 2000
- A Novel Immunoradiometric Assay Detects Full-Length Human PTH but not Amino-Terminally Truncated Fragments: Implications for PTH Measurements in Renal FailureJournal of Clinical Endocrinology & Metabolism, 1999
- Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPDKidney International, 1994
- Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.Journal of the American Society of Nephrology, 1993
- The spectrum of bone disease in end-stage renal failure—An evolving disorderKidney International, 1993
- Comparison of Intact, Midregion, and Carboxy Terminal Assays of Parathyroid Hormone for the Diagnosis of Bone Disease in Hemodialyzed PatientsJournal of Clinical Endocrinology & Metabolism, 1991
- Bone disease in pediatric patients undergoing dialysis with CAPD or CCPDKidney International, 1988
- Quantitative Histological Studies on the Pathogenesis of Uremic Bone Disease*Journal of Clinical Endocrinology & Metabolism, 1974